| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0167-8140(88)90029-1 |
| P698 | PubMed publication ID | 2849147 |
| P2093 | author name string | J Hermans | |
| J W Leer | |||
| E M Noordijk | |||
| A M Wever | |||
| E vd Poest Clement | |||
| P433 | issue | 2 | |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 83-89 | |
| P577 | publication date | 1988-10-01 | |
| P1433 | published in | Radiotherapy and Oncology | Q14251029 |
| P1476 | title | Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer | |
| P478 | volume | 13 |
| Q54056213 | Audit: The use of radiotherapy for NSCLC in the UK |
| Q73153881 | Carbon ion radiotherapy for stage I non-small cell lung cancer |
| Q71666152 | Chemotherapy for advanced non-small-cell lung cancer |
| Q68126282 | Chest radiography or computed tomography in the assessment of lung cancer prior to radiography |
| Q34065009 | Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee |
| Q35543193 | Curative approaches to lung cancer in the elderly |
| Q80100928 | Definitive radiotherapy for stage I non-small cell lung cancer: ain't nothing like the real thing? |
| Q77711995 | Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer |
| Q79331422 | Effect of histologic type on recurrence pattern in radiation therapy for medically inoperable patients with stage I non-small-cell lung cancer |
| Q33635117 | Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer |
| Q35124155 | Elective nodal failures are uncommon in medically inoperable patients with Stage I non–small-cell lung carcinoma treated with limited radiotherapy fields |
| Q33890720 | Evidence-based medicine in the treatment of non-small-cell lung cancer |
| Q73153873 | First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy |
| Q33378130 | From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer |
| Q73701866 | High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer |
| Q73850864 | High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma |
| Q73531778 | Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer |
| Q31055408 | Hypofractionated irradiation for non-small cell lung cancer |
| Q73466989 | Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone |
| Q74404188 | Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer |
| Q47098978 | Initial clinical experience with stereotactic lung radiotherapy, based on a biological model-driven prescription method |
| Q33696590 | Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma |
| Q34054127 | Involved-field radiotherapy alone for early-stage non-small-cell lung cancer |
| Q68259550 | Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchus |
| Q38233871 | Is stereotactic ablative radiotherapy an alternative to surgery in operable stage I non-small cell lung cancer? |
| Q73274541 | Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer |
| Q71877354 | Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer |
| Q73858423 | Lung cancer |
| Q74507575 | Lung cancer |
| Q94093273 | Lung cancer |
| Q33787469 | Lung cancer radiation treatment in the elderly |
| Q67681956 | Management of lung cancer |
| Q33862691 | Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy |
| Q34137842 | Modeling tumor and treated lung volume influences in the irradiation of non-small-cell lung cancer patients |
| Q34259442 | Nonsurgical management of non-small-cell lung cancer |
| Q74518409 | Older people with non small cell lung cancer in clinical stage IIIA and co-morbid conditions. Is curative irradiation feasible? Final results of a prospective study |
| Q78165698 | Percutaneous brachytherapy for small-sized non-small cell lung cancer |
| Q67699641 | Primary, Adjuvant, and Palliative Radiation Therapy |
| Q71843750 | Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone |
| Q74404193 | Quality of life after curative radiotherapy in Stage I non-small-cell lung cancer |
| Q35543221 | Radiation therapy alone in early stage non‐small cell lung cancer |
| Q77344419 | Radiation therapy of stage I and II non-small cell lung cancer (NSCLC) |
| Q33841154 | Radiation therapy of the older patient |
| Q43503478 | Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients |
| Q24187481 | Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable) |
| Q34202691 | Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). |
| Q34558206 | Radiotherapy |
| Q71859536 | Radiotherapy Alone for Non-Small Cell Lung Carcinoma Five-year disease-free survival and patterns of failure |
| Q74619608 | Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer |
| Q73929269 | Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects |
| Q73515337 | Radiotherapy for non-small cell lung cancer in patients aged 75 and over: safety, effectiveness and possible impact on survival |
| Q41313373 | Radiotherapy in the aged. |
| Q40715201 | Radiotherapy in the management of non-small-cell lung cancer |
| Q92651151 | Regulation of response to radiotherapy by β-arrestin1 in Non-small cell lung cancer |
| Q36780656 | Stage I non-small cell lung cancer: results for surgery in a patterns-of-care study in Sydney and for high-dose concurrent end-phase boost accelerated radiotherapy. |
| Q40308740 | Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer |
| Q73371647 | Stereotactic single-dose radiotherapy of stage I non–small-cell lung cancer (NSCLC) |
| Q40431700 | The Curative Treatment by Radiotherapy Alone of Stage I Non-Small Cell Carcinoma of the Lung |
| Q40725993 | The aged patient with lung cancer. Management recommendations. |
| Q34204947 | The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population |
| Q83352619 | The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002 |
| Q35162530 | The role of radiotherapy in treatment of stage I non-small cell lung cancer |
| Q36504885 | Time course from first symptom to treatment in patients with non-small cell lung cancer referred for radiotherapy: a report by the CHART Steering Committee |
| Q26853124 | Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy? |
| Q35074566 | Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer |
| Q67487969 | Treatment of non-small cell lung cancer with external beam radiotherapy and high dose rate brachytherapy |
| Q34882078 | Updates in surgical oncology for elderly patients |
| Q50779417 | Video-assisted thoracoscopic wedge resection of T1 lung cancer in high-risk patients. |
| Q74641229 | [Radiotherapy of the elderly patient. Radiotherapy tolerance and results in older patients] |
| Q50899168 | [Survival of exclusively irradiated patients with NSCLC. Significance of pretherapeutic hemoglobin level]. |
Search more.